People with rheumatoid arthritis (RA) are at a higher risk for infections, including COVID-19, the novel coronavirus that has caused the current worldwide pandemic. COVID-19 is a highly infectious virus that spreads through airborne respiratory droplets. Managing rheumatoid arthritis during COVID-19 is crucial for patients. Living With RA: How to Protect Yourself From COVID-19 – WebMD
Reactive arthritis is also a concern, being relatively common after certain infections, now including SARS-CoV-2, the virus that causes COVID-19. Reactive arthritis involves joint pain and inflammation. Reactive Arthritis Following COVID-19 Infection: What to Know – Healthline
If you have RA, it’s important to take extra steps to protect against COVID-19, as you may have a higher risk for getting the virus or developing severe symptoms. Coronavirus and Rheumatoid Arthritis: Is There a Connection? – Healthline
Studies have reported autoantibodies in patients with COVID-19, including anti-cardiolipin, anti-β2-glycoprotein I, and antinuclear antibodies. The occurrence of Anti-citrullinated protein antibodies (ACPA) and flaring of rheumatoid arthritis (RA) after SARS-Cov-2 infection has also been described. COVID-19 and rheumatoid arthritis – PubMed
Rheumatoid arthritis (RA) is the most common immune-mediated disorder in COVID-19 patients. This review discusses how commonly used drugs in RA alter the patients’ susceptibility to this infection and summarizes the recommendations from major bodies on managing this disease in these times. Onset of rheumatoid arthritis after COVID-19: coincidence or connected – BMJ
For those with RA, it’s crucial to understand the risks and protections regarding COVID-19. RA & Vaccinations During COVID – Arthritis Foundation
In patients with RA, risk factors for severe COVID-19 outcomes include older age and comorbidities similar to those in the general population. Glucocorticoids, but not other classes of disease-modifying antirheumatic drugs (DMARDs), appear to be associated with a higher risk of severe COVID-19 outcomes. Rheumatoid Arthritis and COVID-19: Risks, Research, and More – Healthline
